Next, we performed correlation studies, which revealed that PD‐L1 levels correlate with the JAK2‐V617F mutational burden in granulocytes of MPN patients (p < .0001, R = 0.52; Figure 1E). Here, JAK2 is linked to myeloproliferative disorder.